Prostate Cancer Patient Fact Sheets Archive
An overview of the potential immune-related adverse events that can arise from treatment with checkpoint inhibitors.
Both the chemotherapy regimen selected and therapeutic dose intensity used in treatment factor into the calculation of neutropenia risk.
Traditional genetic testing historically included the sequential analysis of single and generally well-described genes involved in heritable cancers.
Some data suggest that psychotherapy may benefit patients with cancer, but higher-quality research is needed.
The effect of polypharmacy and noncancer mortality on patient survival and other outcomes in cancer varies by study.
Though it is clear that cancer is associated with an extreme financial burden, the extent of the burden varies widely.
There is concern that added nitrates and nitrites are associated with an increased risk of cancer, but epidemiologic data have been inconclusive thus far.
The mechanisms that drive this benefit are not well-understood, and it is believed that the benefit is not just a result of reducing risk factors such as body weight.
An overview of the research regarding the use of massage to improve cancer- or treatment-related symptoms and overall quality of life for patients with cancer.
Multiple studies have examined the possible association between cell phone usage and increased cancer risk, but study designs, potential biases, and interpretations of statistical outcomes leave conclusions uncertain.
All meta-analyses conducted to date show a significant association between indoor tanning use and an increased risk of melanoma or non-melanoma skin cancers.
Though mechanisms of anticancer effects of resveratrol have been identified, the ability to translate these findings to in-human studies is a challenge.
Several meta-analyses suggest that coffee consumption may decrease the risk of many types of cancers, but for some cancers, the data remain mixed or indicate an increased risk.
Though the mechanisms of action of acupuncture are not well-understood and continue to be an area of research, hypotheses include changes in neurohormones and immunomodulation through cytokines.
While some in vitro data suggests anticancer activity, animal and in-human studies fail to show efficacy and the risk of cyanide toxicity make amygdalin not recommended for use.
Cannabis and its synthetic cannabinoids have been studied for medicinal properties across multiple disease states.
In-human studies have evaluated the use of EOs in a supportive role, and though EOs appear to have some efficacy in this setting, larger studies are needed to confirm their effects.
Cascara use is not recommended because there are insufficient data for establishing its safety, and there have been reports of liver injury with high doses.
In vitro and in vivo data suggest that selective amino acid deprivation may have anticancer activity.
Bloodroot-containing products sold as a cure for cancer can be highly toxic and result in disfigurement.
Proponents of Ayurveda claim that it is as effective as Western medicine but few, if any, well-designed clinical trials have been conducted using the Ayurvedic approach.
Preliminary data suggest that alpha lipoic acid, particularly in combination with other compounds, may improve quality of life and may have some anticancer activity.
In vitro and in vivo data suggest that acai berry extracts have anticancer properties, and warrant additional studies in humans.
Oral nicotinamide may reduce the number and size of AKs and prevent the development of new non-melanoma skin cancers among patients at high risk.
Two small studies suggest that AHCC may improve outcomes among patients with liver cancer.
High fish consumption may provide a protective benefit against gastrointestinal cancers, thyroid cancer, multiple myeloma, and childhood leukemia.
Epidemiologic data of flaxseed dietary intake and high enterolactone serum concentrations suggest that flaxseed consumption may reduce the risk of breast cancer.
Epidemiologic evidence suggests that high poultry consumption is not associated with an increased risk of most cancers, including cancer mortality.
The association of cancer risk and alcohol varies by tumor type, as alcohol consumption has been associated with several different types of cancers.
Epidemiologic evidence is mixed regarding the protective effect of garlic consumption against different cancer types.
Epidemiologic data, primarily from case-control studies, suggest that different types of pesticides are associated with specific types of cancer among children and adults.
Epidemiologic evidence suggests that high consumption of red meat, particularly beef, is associated with an increased risk of several types of cancer.
There are no data to suggest that xylitol is carcinogenic or is associated with an increased risk of cancer. Two in vitro studies suggest that xylitol may have antiproliferative properties, but this has not been investigated among human subjects.
Several case-control and prospective cohort studies conducted in a Korean population suggest that ginseng intake can reduce the risk of cancer, though this was not supported by other cohort studies in different populations.
The available human studies do not support the role of Ginkgo biloba as a treatment for cancer, but the published studies were not placebo-controlled, making it difficult to draw conclusions from the data.
In vivo studies suggest that extracts of St John's wort may have apoptotic effects on cancer cells, but human studies have not been conducted to test this hypothesis.
Vitamin E supplementation appears to reduce the risk of chemotherapy-induced neurotoxicity and several radiation-induced toxicities, though one study found increased recurrence rates with its use.
Fish oil supplementation may improve chemotherapy-related outcomes, such as time to tumor progression, and may be protective against certain toxicities.
The data regarding sugar consumption and the increased risk of cancer are not consistent, making it difficult to draw definitive conclusions.
Data indicate that beta-Carotene should not be recommended as a cancer prevention agent due to lack of efficacy and potential harm among smokers or those exposed to asbestos.
This fact sheet is a review of study data about the relationship between zinc supplementation and cancer incidence and outcomes.
There has been great interest in selenium as a potential chemopreventative agent against various types of cancers, particularly of the prostate.
About 60% of Americans are deficient in magnesium, including up to 60% of patients who are critically ill.
Evidence is mixed about the relationship between calcium intake and colorectal/prostate cancers.
Despite controversy, many studies have found no significant association between aspartame consumption and the incidence of different types of solid and hematologic malignancies.
Vitamin A supplementation likely does not reduce chemotherapy efficacy and, for many patients, is unlikely to cause harm.
Though some studies reported improvements in clinical outcomes and quality of life with vitamin C treatment, these findings have not been replicated in randomized controlled studies.
Multiple studies evaluated the role of vitamin B6 in cancer risk and its efficacy as an antitumor or anti-toxicity agent.
Additional large, well-designed studies are needed to clarify the roles of dietary nutrients in HPV infection persistence and cancer risk.
There is limited epidemiologic and lab-experiment evidence that green tea and green tea compounds are capable at high concentrations of affecting tumor biology.
The anticancer activity of cranberry has not yet been tested in humans, though preclinical data suggest that cranberry extract may help to treat cancer.
Aspirin may play a role in preventing and reducing cancer-specific mortality of particular cancers, including gastrointestinal cancers, pancreatic cancer, and prostate cancer.
It's equivocal whether shiitake mushroom supplements benefit any patients with cancer.
NCCN guidelines recommend that smoking cessation be provided as part of oncology treatment.
There is not enough evidence to conclude that vitamin D dietary supplements are an effective intervention for reducing cancer risk or improving cancer outcomes.
Several studies evaluated whether Reishi mushroom-use has an anticancer effect, either alone or synergistically with other treatments.
Recent research is inconsistent about whether turmeric supplements can prevent and treat cancer.
This fact sheet explains what follow-up cancer care is and what patients can expect from it.
This fact sheet explains what a cancer prognosis is and how to understand which factors may impact it.
This patient fact sheet defines palliative care in nursing and hospice and outlines common issues.
This fact sheet answers common questions patients may have about palliative care.
This fact sheet contains helpful tips for the grieving process in those who have experienced the death of a loved one.
This fact sheet provides signs, symptom management tips, treatment options, and more for younger patients coping with cancer.
This fact sheet provides resources, organizations, and agencies for cancer patients to seek out financial assistance.
This fact sheet offers Spanish-speaking cancer caregivers tips about how to take time to care for themselves.
This fact sheet offers tips for helping teenagers cope with the loss of a parent to cancer.
This fact sheet offers tips to caregivers and loved ones focused around caring for themselves during this difficult time.
This fact sheet for Spanish-speaking patients lists a number of cancer organizations and agencies that provide financial assistance.
This fact sheets details ways to manage stress, a common occurence among caregivers who struggle to meet competing demands.
This fact sheet answers questions about chemobrain and how patients can communicate to their health care team about it.
This fact sheet for Spanish-speaking patients provides tips for doctors communicating with their health care team.
This fact sheets helps patients to offer care and support systems with cancer caregivers.
This fact sheet helps patients prepare for appointments with a list of questions they can ask to help understand treatment.
This fact sheet answers some common questions about prostate cancer, bone scan, and metastasis.
This patient fact sheet contains tips for coping with cancer during the holiday season.
This fact sheet describes services available to people diagnosed with cancer and their loved ones.
This fact sheet offers tips on how to communicate your cancer diagnosis with your children.
This fact sheet offers tips on how to support a loved one recently diagnosed with cancer.
This fact sheet reviews current prostate cancer screening tests, guidelines, PSA, and risk factors.
This fact sheet helps patients learn the different types of healthcare professionals who will help you during cancer treatment.
This fact sheet answers common questions about clinical trials to bring about progress in cancer treatment.
This fact sheet informs patients on palliative hospice care and what services are offered to them at the end of life.
This fact sheet offers tips for younger patients for during and after cancer, chemotherapy treatment, diagnosis, symptoms.
This fact sheet educates patients on how to establish and improve concentration during cancer therapy, chemotherapy.
This fact sheet reviews a number of relaxation techniques that cancer patients can use.
This fact sheet addresses some common questions about hair loss during cancer treatment, causes, symptoms, and treatment.
This patient information fact sheet details diets and lifestyle methods known to aid in cancer prevention.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Real-World Study Shows High Response Rates to T-VEC in Early Metastatic Melanoma
- Are Next-Gen Antibody-Drug Conjugates a Path Forward for Non-Hodgkin Lymphoma and Myeloma?
- Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection
- Ponatinib Tops Bosutinib for Third-Line Treatment of CML in a Comparative Analysis
- Plastics and Cancer
- FDA-Approved Breast Cancer Drug Treatments
- A Trained Dog Smells Early-Stage Lung Cancer With a High Degree of Accuracy
- FDA-Approved Colorectal Cancer Drug Treatments
- Synthetic or Plant-Based Cannabis for Symptom Relief in Patients With Cancer: Do We Have Any Evidence?
- Emetogenic Potential of Antineoplastic Agents
- 20-Year Data Link High-Dose Chemotherapy and Hematopoietic Stem Cell Transplant to Survival Benefit in High-Risk Early Breast Cancer
- Cabozantinib Shows Promising Activity in Osteosarcoma and Ewing Sarcoma
- Reducing Trastuzumab Duration Lowers Costs by Nearly £10,000 in HER2-positive Breast Cancer
- Resistance Mechanisms Identified for NSCLC Progression With First-Line Osimertinib
- Atezolizumab and Nab-Paclitaxel Prolonged PFS in Metastatic Triple-Negative Breast Cancer